Novo Nordisk A/S Statistics
NYSE: NVOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
37.82-1.05 (-2.70%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Novo Nordisk A/S by the numbers
Novo Nordisk A/S has a market capitalization of $166.69 billion based on 3.33B shares outstanding. Its trailing P/E ratio is 9.6, below the 8-company peer median of 28.1, and its forward P/E is 10.8. The stock trades 4.5% below its 50-day average and 11.8% below its 200-day average.
Average daily trading volume is 12.59M shares, or about $476.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NVO valuation vs. peer median
| Metric | NVO | Peer median | Difference |
|---|---|---|---|
| Market cap | $166.69B | $115.95B | +44% |
| P/E (TTM) | 9.6 | 28.1 | -66% |
| Forward P/E | 10.8 | 11.2 | -4% |
| Dividend yield | 30.94% | 4.29% | +622% |
| Avg. volume | 12.59M | 3.72M | +239% |
Peer median across 8 companies: PFE, ABT, VRTX, BMY, SNY, GSK, REGN, TAK.
Valuation
- Market cap
- $166.69B
- P/E (TTM)
- 9.55
- Forward P/E
- 10.77
- EPS (TTM)
- $3.96
- Shares outstanding
- 3.33B
Price and trading
- Previous close
- 38.87
- Open
- 38.44
- Day range
- 37.75 – 39.11
- 52-week range
- 35.12 – 64.16
- 52-week change
- -20.60%
- Beta
- —
- Volume
- 13.04M
- Average volume
- 12.59M
Dividends and events
- Annual dividend
- $11.70
- Dividend yield
- 30.94%
- Next earnings date
- Feb 3, 2027
Additional statistics
- Market Cap
- 166.69B
- Pe
- 9.55
- Forward Pe
- 10.77
- Eps
- 3.96
- Dividend Yield
- 4.75%
- Dividend Rate
- 11.70
- Week52 High
- 64.16
- Week52 Low
- 35.12
- Avg Volume
- 12.59M
- Shares Outstanding
- 3.33B
- Ma50
- 39.59
- Ma200
- 42.88
- Earnings Date
- Feb 3, 2027
- Pct From52w High
- -41.05%
- Pct From52w Low
- 7.69%